Joint Ventures
We are specialists in joint ventures and strategic alliances.
Our Corporate Finance practice specialises in advising on joint ventures and strategic alliances. As a core part of our offering, we support investors and entrepreneurs, advising them on structuring, drafting and negotiating joint venture agreements.
Because we work collaboratively across all our practice groups, we also offer a broad range of supporting advice in areas such as intellectual property rights and exploitation, regulation and licensing, antitrust, commercial agreements, real estate, tax, employment and benefits. We have experience in advising on a wide range of joint venture structures and can advise on the commercial and strategic issues involved, as well as dealings with local regulators.
We have acted on a significant number of joint ventures for corporates, international investment houses and banks across the globe. Our clients entrust us with their highest profile work in this area and your Allen & Overy team will draw on this experience and know-how to deliver commercial and cost effective advice.
Explore our services
Meet our lawyers
News and insights
News: 29 November 2023
A&O advises Ferrovial on the sale of its investment in Heathrow airport
Allen & Overy (A&O) is advising Ferrovial on the sale of its c.25% indirect interest in Heathrow Airport Holdings Limited (Heathrow).
Publications: 05 October 2023
Funds use range of techniques to fill funding gaps and navigate M&A valuation mismatches
From NAV financings to preferred equity, holdco PIK financings and partial sales, sponsors are finding creative ways to navigate current market volatility. Here we explain what to look out for in…
Blog Post: 04 January 2023
Why AI drug discovery deals are different from traditional pharma collaborations
Pharma companies have been working with artificial intelligence (AI) for a decade or more. As the cost and time of bringing a new drug to market continues to rise, pharma companies are increasingly…
Publications: 20 December 2022
Why AI drug discovery deals are different from traditional pharma collaborations
Pharma companies have long collaborated with other organisations to bring new drugs to market. But what happens when their partner is an artificial intelligence (AI) company rather than another pharma…
Recognition
They have been able to work through the complexities of the deal, and been very efficient and responsive. The completion was smooth.
Chambers Europe 2018 (Corporate/M&A)
Relevant experience and global footprint.
Chambers Europe 2018 (Corporate/M&A)
Platinum service and the highest-quality advice. They know their market and their areas incredibly well.
Chambers UK 2018 (Corporate/M&A)
Download our practice brochure
Our Corporate Finance practice specialises in advising on joint ventures and strategic alliances. As a core part of our offering, we support investors and entrepreneurs, advising them on structuring, drafting and negotiating joint venture agreements.